8-K

                   SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C. 20549

                                FORM 8-K

                             CURRENT REPORT

                PURSUANT TO SECTION 13 OR 15(d) OF THE
                    SECURITIES EXCHANGE ACT OF 1934


   Date of Report (Date of earliest event reported):  July 8, 2002


                     BIO-RAD LABORATORIES, INC.
   _________________________________________________________________
           (Exact Name of Registrant as Specified in Charter)


   A Delaware Corporation             1-7928              94-1381833
   _________________________________________________________________
   (State or Other Jurisdiction     (Commission        (IRS Employer
      of Incorporation)              File  Number)  Identification No.)


   1000 Alfred Nobel Drive, Hercules, California               94547
   _________________________________________________________________
   (Address of Principal Executive Offices)                 (Zip Code)

   Registrant's telephone number, including area code  (510)724-7000


                               No Change
   _________________________________________________________________
     (Former Name or Former Address, if Changed Since Last Report)







ITEM 4. CHANGES TO REGISTRANT'S CERTIFYING ACCOUNTANTS.

On July 8, 2002, Bio-Rad Laboratories, Inc. ("Bio-Rad") dismissed Arthur
Andersen LLP ("Andersen") as its independent public accountants, and
appointed Deloitte & Touche LLP ("Deloitte & Touche") as its new independent
public accountants.  The decision to change independent public accountants
was recommended by the Audit Committee and approved by the Board of Directors
of Bio-Rad.

The report of Andersen for the fiscal years ended December 31, 2001
and 2000 contained no adverse opinions, disclaimer of opinion or qualifications
or modification as to uncertainty, audit scope or accounting principles.  During
the fiscal years ended December 31, 2001 and 2000, and the interim period from
January 1, 2002 through July 8, 2002 there were no disagreements between Bio-Rad
and Andersen on any accounting principles or practices, financial statement
disclosure or auditing scope or procedure, which, if not resolved to the
satisfaction of Andersen would have caused it to make reference to the subject
matter of the disagreement in connection with its report.

No event described in paragraph (a)(1)(v) of Item 304 of Regulation S-K has
occurred within Bio-Rad's fiscal years ending December 31, 2001 and 2000 or
the period January 1, 2002 through July 8, 2002.

Bio-Rad has provided Andersen with a copy of the foregoing disclosures and
requested a letter from Andersen addressed to the Securities and Exchange
Commission stating whether it agrees with such statements.  Andersen has
orally advised the Company that due to recent events impacting Andersen's
infrastructure it is unable to issue such a letter.

Bio-Rad did not consult with Deloitte & Touche during the fiscal years ended
December 31, 2001 and 2000, and the interim period from January 1, 2002 through
July 8, 2002 on any matter which was the subject of any disagreement or any
reportable event or on the application of accounting principles to a specified
transaction, either completed or proposed.


ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

(a) Not applicable

(b) Not applicable

(c) Exhibits

    16.0  Press release dated July 9, 2002

          Bio-Rad Selects Deloitte and Touche LLP As Independent
          Public Accountants.


                              SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                       BIO-RAD LABORATORIES, INC.
                                       (Registrant)

Date:  July 9, 2002                    by:  /s/ Sadford S. Wadler
                                            ---------------------
                                            Sanford S. Wadler,
                                            Vice President, General Counsel
                                            and Secretary

EX-16

EXHIBIT 16.0


NEWS RELEASE


Bio-Rad Selects Deloitte and Touche LLP As Independent Public Accountants

HERCULES, CA, July 9, 2002 - Bio-Rad Laboratories, Inc. (AMEX: BIO and BIO.B)
announced today that its Board of Directors, after extensive review and at the
recommendation of its Audit Committee and the Company's management, has
selected Deloitte and Touche LLP as Bio-Rad's independent public accountants
for 2002.  Prior to the selection of Deloitte and Touche, Arthur Andersen LLP
served as the Company's independent public accountants.

Arthur Andersen LLP exhibited the highest level of professionalism and provided
exemplary service to Bio-Rad Laboratories, Inc. since 1971.  The decision to
change accountants was made after careful consideration and is not the result
of any disagreement between the Company and Arthur Andersen LLP on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure.

Bio-Rad Laboratories, Inc. (www.bio-rad.com) is a multinational manufacturer
and distributor of life science research products and clinical diagnostics.
It is based in Hercules, California, and serves more than 70,000 research and
industry customers worldwide through a network of more than 30 wholly owned
subsidiary offices.

For more information, contact:
Ron Hutton, Treasurer
Phone: (510) 724-7000
E-mail: investor_relations@bio-rad.com